M&A Deal Summary

L2P Research Acquires Metis Laboratories

On February 28, 2020, L2P Research acquired life science company Metis Laboratories

Acquisition Highlights
  • This is L2P Research’s 1st transaction in the Life Science sector.
  • This is L2P Research’s 1st transaction in the United States.
  • This is L2P Research’s 1st transaction in New York.

M&A Deal Summary

Date 2020-02-28
Target Metis Laboratories
Sector Life Science
Buyer(s) L2P Research
Deal Type Add-on Acquisition

Target

Metis Laboratories

Ronkonkoma, New York, United States
Metis Laboratories, Inc. provides radiotracer services for pharma, biotech, and academic organizations across the world. Metis offer standard and specialized services in the areas of radioligand binding assays (HTS), receptor occupancy determinations, autoradiography, Quantitative Whole-Body autoradiography, ADME-PK, small animal imaging, and custom radiolabeling & synthesis. Metis Laboratories was established in 2010 and is based in Ronkonkoma, New York.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

L2P Research

Pennsylvania, United States

Category Company
Sector Life Science
DESCRIPTION

L2P Research LLC is a research organization that provides integrated R&D support in all the key areas of Pharmaceutical development. With a large worldwide customer base, L2P provides a complete array of research services as required for Investigational New Drug Applications (IND).


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New York M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1